SANUWAVE Health Inc

SNWV

Market cap $272M

Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of its UltraMIST product line to Healogics iSupply.

SANUWAVE Health, Inc. ( SNWV ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Morgan Frank - CEO & Chairman Peter Sorensen - CFO & Secretary Conference Call Participants Ian Cassel - Intelligent Fanatics Capital Management Llc Kyle Bauser - ROTH Capital Partners, LLC, Research Division Carl Byrnes - Northland Capital Markets, Research Division Alex Silverman - AWM Investment Company Inc Andrew Rem Presentation Operator Good day, everyone, and welcome to the SANUWAVE earnings call. [Operator Instructions] Please note, this call may be recorded.

Sanuwave Health Inc. (SNWV) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to a loss of $6.49 per share a year ago.

Q3 2025 revenues were  $11.5 million , up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history.

EDEN PRAIRIE, Minn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, November 7, 2025, at 8:30 AM (ET) to present its Q3 2025 financial results.

Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Tuesday.

Sanuwave Health (SNWV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

SANUWAVE Health, Inc. (NASDAQ:SNWV ) Q3 2025 Earnings Call October 6, 2025 5:30 PM EDT Company Participants Morgan Frank - CEO & Chairman Conference Call Participants Kyle Bauser - ROTH Capital Partners, LLC, Research Division Carl Byrnes - Northland Capital Markets, Research Division Presentation Operator Good day, everyone, and welcome to the SANUWAVE Q3 Revenue Update. [Operator Instructions] Please note today's call will be recorded.

Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history.